Herban Healing, LLC, Pioneering Bio-Pharmaceutical Innovations in Hospice Care, Expands Reach to 34 Facilities

Herban Healing, LLC, Pioneering Bio-Pharmaceutical Innovations in Hospice Care, Expands Reach to 34 Facilities

  • Herban Healing, LLC celebrates a remarkable expansion to 34 hospice facilities nationwide, a significant achievement in its mission to provide compassionate alternatives for end-of-life care.
  • Herban Healing launches a comprehensive outreach initiative to educate healthcare providers, patients, and families about the transformative potential of CBD-based alternatives in hospice care.
  • Herban Healing partners with VitalPoint Technologies to amplify research efforts and explore potential applications of alternative medicine beyond the hospice market.
  • The U.S. hospice market, valued at USD 33.06 Billion in 2022, is expected to reach USD 80.96 Billion by 2032, driving Herban Healing’s expansion efforts.
  • Herban Healing aims to combat opioid withdrawal syndrome by advancing research and potential clinical trials with validated data collected from hospice care partners.

Houston, Texas – April 25th, 2024 – VitalPoint Technologies, Inc. (“VPT”) proudly announces the remarkable expansion of Herban Healing, LLC (“Herban”), a Texas-based bio-pharmaceutical company spearheading innovative healthcare solutions since its inception in 2019. Today, Herban Healing celebrates a significant milestone as it extends its outreach to 34 hospice facilities nationwide. 

As part of this milestone achievement, Herban Healing, LLC is launching a comprehensive outreach initiative aimed at educating healthcare providers, patients, and their families about the transformative potential of CBD-based alternatives in hospice care. Through targeted communication channels, including seminars, webinars, and informational materials, Herban Healing seeks to empower individuals with knowledge about these innovative solutions. Join us today and be a part of this groundbreaking movement.

Founded by siblings, Kyle Williams and Jennifer Gilleland, LVN, Herban Healing was established with a profound mission: to offer compassionate alternatives for patients navigating end-of-life scenarios. Witnessing an enthusiastic response from patients and families, particularly regarding CBD-based alternatives over conventional hospice care methods or morphine, Herban Healing has emerged as a beacon of hope within the hospice community.

Kyle Williams, CEO and Co-Founder of Herban Healing, expressed his enthusiasm for partnering with VitalPoint Technologies, stating, “Through VitalPoint Technologies, we are empowered to collaborate with academia and industry to amplify research efforts, raise awareness, and explore the potential applications of alternative medicine. While initially focusing on the hospice market, we are eager to extend our impact to the veterans community and addiction facilities, ensuring access to the finest available options for those in need.”

Interested Hospice operators that would like to find out about this program are encouraged to download our Herban Healing Hospice Overview and contact Jennifer Gilleland at [email protected]

Addressable Market in Hospice Care

The U.S. hospice market was valued at USD 33.06 Billion in 2022 and grew at a CAGR of 9.37% from 2023 to 2032. The market is expected to reach USD 80.96 Billion by 2032. As the baby boomer generation retires, this trend is expected to escalate, amplifying the need for innovative healthcare solutions. To capitalize on this trend we are bringing in a strategic adviser with significant operating history in this industry that will be introduced in the coming weeks.

Overcoming formidable supply chain challenges and entry barriers, the Co-Founders of Herban Healing have meticulously developed a proprietary blend of hemp-derived biopharmaceuticals over three years. The tangible success stories, amplified by word-of-mouth recommendations and testimonials from healthcare professionals and patients, underscore the efficacy of Herban Healing’s offerings. However, further research and potential clinical trials are imperative to fortify Herban Healing’s bio-technology ambitions.

Advancing Anti-Opioid Research

Citing a publication from the National Library of Medicine, CBD has demonstrated several therapeutic properties, including anti-inflammatory, analgesic, and reduction of cue-induced craving for opioids. Moreover, CBD has exhibited remarkable tolerability, even when co-administered with potent opioid agonists, highlighting its potential in combating opioid withdrawal syndrome. 

Herban Healing has spent the last four years collecting and validating data with their Hospice care partners in order to best map out our distribution plan and provide fact based research for healthcare professionals to make decisions with. This cumulative of data now sets the stage for VPT to be able to advance the research or trials with academic or industry partners. Details on the results of these findings will be shared in upcoming announcements. 

About VitalPoint Technologies, Inc.

VitalPoint Technologies, Inc. is founded by a collective of veterans, medical professionals, and financial advocates who envision a future where technology places individuals’ well-being at the forefront of healthcare. We are deeply committed to leveraging tech-enablement for alternative healthcare options, such as CBD and psilocybin, to address pressing healthcare challenges. Our goal is not just to develop products but to automate processes that facilitate research, regulatory compliance, and education within the healthcare ecosystem.

Corporate Website:                   https://VitalPointTech.com
Herban Healing:                        https://Herban-Healing.com


Robert Yrshus, Executive Chairman

Address:   3730 Kirby Drive # 1200

                   Houston, TX 77098

Phone:      1-512-522-0360‬

Email:       [email protected]   

Forward-Looking Statements Certain statements herein, including statements regarding the extent and timing of our production and other operations, and our liquidity, are “forward-looking statements” that are subject to risks and uncertainties. These forward-looking statements are based on management’s current expectations. Various important factors could cause actual results to differ materially, including the risks identified in our filings with the Securities and Exchange Commission. VitalPoint Technologies, Inc. disclaim any obligation to update this information. Certain statements in this press release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases.  You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.

Read Full Disclaimer:https://vitalpointtech.com/disclaimer/  

Scroll to Top